• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec1
FDA Warns DexCom Over Unauthorized Design Changes in Glucose Monitors
12:55
Nov28
Rockefeller Capital Management Buys Shares of DexCom in Q2
10:29
Nov27
Rhenman & Partners Increased Holdings in DexCom
12:27
Nov24
Oppenheimer Downgrades DexCom Inc. Rating and Removes Price Target
14:03
Nov21
Eagle Health Investments LP reduces holdings in DexCom
09:49
Nov20
DexCom Launches Dexcom G7 15-Day Continuous Glucose Monitoring System
13:31

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.209 B, Net Income 283.8 M, EPS 0.7034

Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.157 B, Net Income 179.8 M, EPS 0.4475

May1
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.036 B, Net Income 105.4 M, EPS 0.2657

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More